Skip to main content
BTAI logo

BTAI

BioXcel Therapeutics, Inc.
$1.10 -0.28 (-20.29%) At close · Jul 6
Market Cap
$33.97M
Shares
30,877,605

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 40
Total Value: $7,290,941
Total Shares: 5,441,014

Institutional Ownership Trend

5 quarters

Holder Concentration

Across 40 13F filers · Δ vs Dec 31, 2025
Top Holder
35.6%
Mar 2025 → Mar 2026 · range 35.6% – 51.9%
−16.3 pts
Top 5
83.2%
Mar 2025 → Mar 2026 · range 70.0% – 83.2%
+6.5 pts
Top 10
92.3%
Mar 2025 → Mar 2026 · range 88.1% – 97.8%
+1.8 pts
HHI
2,576
Mar 2025 → Mar 2026 · range 1,896 – 2,905
Highly concentrated−329

Quarterly Activity

vs Dec 31, 2025
New
8
Increased
9
Decreased
7
Sold Out
9
Unchanged
16
Holder count: -1
Institutional value: +28.8%
Shares held: +53.8%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 40 of 40
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1720893 CUSIP 09075P204 Visit website Investor relations